We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Model-Based Iterative Reconstruction CT Technology Offers Very Low Dose Capabilities

By HospiMedica International staff writers
Posted on 30 Jan 2012
A new computed tomography (CT) system is the world’s first model-based iterative reconstruction product. More...


This advance is changing the way physicians use CT imaging. It may provide a combination of high-quality images and ultra-low dose capabilities that was previously unattainable.

GE Healthcare (Chalfont St. Giles, UK) has solved image reconstruction challenges in partnership with leading healthcare partners and hardware manufacturers, combining advanced algorithms and sophisticated computing power.

Veo establishes new rules in the relationship between image quality and dose reduction. The system can provide the clinicians with the diagnostic data they need and may allow CT scanning to be performed at previously inconceivable ultra-low dose capabilities.

The benefits of dose reduction are significant, particularly for the most radiosensitive patients, including children, young women, and patients who require regular follow-up exams.

The ASiR (adaptive statistical iterative reconstruction) technology offers fast reconstructions and may allow for low-dose imaging without compromise--a suitable approach for routine, effective imaging. By pushing the boundaries even further, Veo represents added capability for the most sensitive cases. These potential dose-reduction capabilities offer exciting new possibilities in CT.

“With Veo, we can conduct lower dose CT scans in children and young adults, this is particularly important in patients that require continued follow up, such as those with cystic fibrosis, lymphoma, or Crohn’s disease,” stated Dr. Koenraad H. Nieboer, from UZ Brussel (Brussels Belgium).

Related Links:
GE Healthcare



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hybrid Arch Device
Neo EDE
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.